Nexvax2

#	Item
1	FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company Add to Reading List Source URL: www.immusant.com Language: English - Date: 2016-05-24 10:55:48 Medicine Gluten sensitivity Clinical medicine Health Nexvax2 Coeliac disease HLA-DQ2 Gluten challenge test Human leukocyte antigen HLA-DQ Gluten-free diet Autoimmunity
2	FOR IMMEDIATE RELEASE ImmusanT’s Immunotherapy for Celiac Disease, Nexvax2, Selected as One of Informa’s Top 10 Autoimmune/Anti-Inflammatory Projects to Watch CAMBRIDGE, Mass. — Nov. 19, 2014 — ImmusanT Inc., a Add to Reading List Source URL: www.coeliac.org.au Language: English - Date: 2014-12-01 00:16:33 Autoimmune diseases Diets Coeliac disease Malnutrition Pediatrics Immunotherapy Gluten-free diet Gluten Autoimmunity Medicine Health Immunology
3	Celiac Disease & Nexvax2® Fact Sheet Add to Reading List Source URL: www.immusant.com Language: English - Date: 2013-05-20 11:49:42 Autoimmune diseases Diets Sensitivities Coeliac disease Pediatrics Gluten-free diet Gluten Immunotherapy HLA-DQ2 Medicine Health Immunology